Yarbrough Capital’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,714
| Closed | -$205K | – | 222 |
|
|
2022
Q4 | $205K | Sell |
1,714
-1,082
| -39% | -$129K | 0.02% | 166 |
|
|
2022
Q3 | $297K | Hold |
2,796
| – | – | 0.02% | 159 |
|
|
2022
Q2 | $273K | Sell |
2,796
-807
| -22% | -$78.8K | 0.02% | 158 |
|
|
2022
Q1 | $338K | Buy |
3,603
+807
| +29% | +$75.7K | 0.02% | 179 |
|
|
2021
Q4 | $238K | Buy |
+2,796
| New | +$238K | 0.01% | 206 |
|